Premium
Edgewise Therapeutics Inc (EWTX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | Institution | 15 518 492 | 14,42% | US$ 635,02M | 2026-03-31 |
| OrbiMed Private Investments VI, LP | Institution | 14 809 075 | 13,76% | US$ 605,99M | 2025-05-12 |
| RA Capital Management, L.P. | Institution | 10 428 437 | 9,69% | US$ 426,73M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 7 365 038 | 6,85% | US$ 301,38M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 6 575 940 | 6,11% | US$ 269,09M | 2026-03-31 |
| BlackRock, Inc. | Institution | 6 472 991 | 6,02% | US$ 264,87M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 6 395 546 | 5,94% | US$ 261,71M | 2025-03-31 |
| Janus Henderson Group plc | Institution | 5 915 556 | 5,50% | US$ 242,06M | 2026-03-31 |
| Baker Brothers Life Sciences, L.P. | Institution | 5 424 167 | 5,04% | US$ 221,96M | 2024-09-30 |
| Novo Holdings A/S | Institution | 5 350 000 | 4,97% | US$ 218,92M | 2026-04-23 |
| Driehaus Capital Management LLC | Institution | 4 477 942 | 4,16% | US$ 183,24M | 2026-03-31 |
| Artal Group S.A. | Institution | 4 430 263 | 4,12% | US$ 181,29M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 4 423 974 | 4,11% | US$ 181,03M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 4 181 497 | 3,89% | US$ 171,11M | 2025-01-27 |
| Vanguard Capital Management, LLC | Institution | 3 788 161 | 3,52% | US$ 155,01M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 3 260 000 | 3,03% | US$ 133,40M | 2026-03-31 |
| Braidwell LP | Institution | 2 347 583 | 2,18% | US$ 96,06M | 2026-03-31 |
| Morgan Stanley | Institution | 2 196 230 | 2,04% | US$ 89,87M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 789 819 | 1,66% | US$ 73,24M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 1 722 169 | 1,60% | US$ 70,47M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 716 823 | 1,60% | US$ 70,25M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 660 696 | 1,54% | US$ 67,96M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 1 600 000 | 1,49% | US$ 65,47M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 1 528 518 | 1,42% | US$ 62,55M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 1 449 915 | 1,35% | US$ 59,33M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1 425 845 | 1,33% | US$ 58,35M | 2026-03-31 |
| Deerfield Private Design Fund IV, L.P. | Institution | 1 301 626 | 1,21% | US$ 53,26M | 2024-09-30 |
| Bank of America Corporation | Institution | 1 267 319 | 1,18% | US$ 51,86M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1 219 717 | 1,13% | US$ 49,91M | 2026-03-31 |
| American Century Investment Management Inc | Institution | 1 147 176 | 1,07% | US$ 46,94M | 2026-03-31 |
| New Leaf Venture Partners, LLC | Institution | 1 030 161 | 0,96% | US$ 42,15M | 2025-09-30 |
| FMR LLC | Institution | 1 017 014 | 0,95% | US$ 41,62M | 2026-03-31 |
| First Light Asset Management, LLC | Institution | 1 001 846 | 0,93% | US$ 41,00M | 2026-03-31 |
| Aberdeen Group Plc | Institution | 826 059 | 0,77% | US$ 33,80M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 825 910 | 0,77% | US$ 33,80M | 2026-03-31 |
| Victory Capital Management Inc. | Institution | 789 043 | 0,73% | US$ 32,29M | 2026-03-31 |
| Norges Bank Investment Management | Institution | 751 355 | 0,70% | US$ 30,75M | 2025-12-31 |
| Artisan Partners Limited Partnership | Institution | 659 067 | 0,61% | US$ 26,97M | 2026-03-31 |
| Marshall Wace LLP | Institution | 648 393 | 0,60% | US$ 26,53M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 596 310 | 0,55% | US$ 24,40M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
